PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490305
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1490305
The Nanoparticle Tracking Analyzer Market size was valued at USD 297.39 million in 2023, expanding at a CAGR of 9.12% from 2024 to 2032.
Nanoparticle Tracking Analysis (NTA) is a method used to analyze nanoparticles in suspension within the size range of 10 - 2000 nm. By utilizing a microscopic system, particles can be visualized in real-time, even below the diffraction limit of traditional microscopes, in both scatter and fluorescence modes. NTA is a versatile technique that can be applied to a wide array of nanoparticles, including metallic particles, polymers, viruses, and extracellular vesicles, regardless of the refractive index of the material. Its applications extend to measuring the size, concentration, or zeta potential of various inorganic particles like silicon dioxide, polymers, calcites, phosphates, barium sulfate, carbon nanotubes, and nanobubbles. Additionally, NTA can be used to analyze different types of bionanoparticles (BNP) such as protein aggregates, extracellular particles (e.g. exosomes or EVs), viruses, or liposomes, with the option of fluorescence labeling and without the need for any additional substances.
Nanoparticle Tracking Analyzer Market- Market Dynamics
The market growth is anticipated to be further accelerated by the increasing emphasis on the development of innovative targeted therapeutics and the integration of artificial intelligence and machine learning algorithms in NTA analyzers.
The pharmaceutical and biotechnology industries are increasingly focusing on developing new targeted therapeutics. In 2022, CDER approved 37 novel drugs, either as new molecular entities (NMEs) under New Drug Applications (NDAs) or as new therapeutic biological products under Biologics License Applications (BLAs), according to the U.S. Food and Drug Administration. The integration of AI and ML algorithms into NTA analyzers enhances their analytical capabilities, enabling more precise and faster analysis of nanoparticles, which improves data accuracy and interpretation. 22% of companies are actively pursuing the integration of AI across various technology products and business workflows, as reported by AI statistics. Moreover, increased funding for nanotechnology research from governments and private entities supports the development and adoption of advanced NTA technologies, presenting growth opportunities for the market. However, the high cost of equipment may hinder market growth.
Nanoparticle Tracking Analyzer Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.12% over the forecast period (2024-2032)
Based on product type segmentation, Instrument & Accessories was predicted to show maximum market share in the year 2023
Based on application segmentation, Viral Vaccine Research & Development was the leading type in 2023
Based on End-User segmentation, Academic Research Institutions were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Nanoparticle Tracking Analyzer Market is segmented based on Product Type, Application, End-User, and Region.
The market is categorized into three segments according to the type of product: Instruments & Accessories and Services. The dominance in the market lies within the Instrument & Accessories segment. With ongoing research on nanoparticles' properties and applications, there is an increasing demand for adaptable and dependable instrumentation, complemented by a variety of accessories and services.
The market is segmented into three categories according to their application: Viral Vaccine Research & Development, Exosomes and Extracellular Vesicles Characterization, Drug Development & Discovery, Protein Aggregation Studies, Nanotoxicology, and Others. The dominant sector in the market is Viral Vaccine Research & Development. Nanoparticles have a significant role in viral vaccine research and development, serving as delivery vehicles for antigens or genetic material, thereby improving vaccine effectiveness and stability.
The market is segmented into two groups according to the end-users: Academic Research Institutions, Pharmaceutical & Biotechnology Companies, and Others. The dominance in market growth lies with Academic Research Institutions. Within academic settings, nanoparticle tracking analyzers find extensive applications such as characterizing nanoparticles for drug delivery systems, studying extracellular vesicles for biomarker discovery, and investigating viral particles for vaccine development.
Nanoparticle Tracking Analyzer Market- Geographical Insights
Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. North America leads the market, driven by the surge in drug discovery efforts by pharmaceutical and biotechnology companies. Particularly in the United States, North America is home to several prominent pharmaceutical and biotechnology firms. These companies allocate significant resources towards research and development (R&D) to innovate new drugs and therapies, consequently fueling the demand for sophisticated analytical tools such as NTAs. As per the Pharmaceutical Research and Manufacturers Association (PhRMA), biopharmaceutical companies invested approximately USD 97 billion in R&D in the U.S. in 2018, with over USD 17 billion in biopharmaceutical exports originating from predominantly foreign-owned companies operating in the United States. During the same year, these foreign-owned companies spent around USD 20 billion on R&D. Foreign direct investment in pharmaceuticals and medicines reached USD 511.3 billion in 2019. Europe stands as the second largest region for market growth, attributed to the high adoption rate of advanced technologies.
The market for Nanoparticle Tracking Analyzers (NTAs) is fiercely competitive, as numerous prominent companies are dedicated to advancing technology and gaining a larger market share. These companies are consistently pouring resources into research and development to improve the performance of NTAs, including enhancing sensitivity, precision, and the capacity to analyze a wider spectrum of particle sizes. Competition within the NTA market is characterized by ongoing innovation, strategic partnerships, and a commitment to broadening the scope of applications across various scientific and industrial sectors. To meet the increasing need for nanoparticle analysis, companies are expanding their operations in emerging markets in Asia-Pacific and Latin America.
The advanced engineering of the new NanoSight Pro nanoparticle tracking analysis (NTA) system from Malvern Panalytical presents a sleek and compact design, making it an ideal choice for laboratories with high activity. This cutting-edge system offers the fastest, simplest, and most comprehensive NTA solution for accurately characterizing bio- and nanomaterials.
Agilent Technologies Inc. has unveiled the NanoDis System for nanoparticle dissolution testing. By integrating Agilent instrumentation and software, this system allows customers to comply with 21 CFR Part 11 and other regulations. The NanoDis System offers a specialized workflow that can be automated and audited for enhanced efficiency.
GLOBAL NANOPARTICLE TRACKING ANALYZER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Particle Technology Labs
Agilent Technologies
Horiba Scientific
Solmeglas
Coriolis Pharma
Cell Guidance System
Particle Metrix
Others